1.Figurate Paraneoplastic Urticaria and Prostate Cancer.
Adone BARONI ; Franco FACCENDA ; Russo TERESA ; Vincenzo PICCOLO
Annals of Dermatology 2012;24(3):366-367
No abstract available.
Prostate
;
Prostatic Neoplasms
;
Urticaria
2.Generalized Idiopathic Benign Acanthosis Nigricans in Childhood.
Vincenzo PICCOLO ; Teresa RUSSO ; Rosalba PICCIOCCHI ; Marilena ERRICO ; Orsola AMETRANO ; Elvira MOSCARELLA
Annals of Dermatology 2013;25(3):375-377
No abstract available.
Acanthosis Nigricans
3.Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis
Antonio CAROTENUTO ; Teresa COSTABILE ; Marcello MOCCIA ; Fabrizia FALCO ; Maria PETRACCA ; Barbara SATELLITI ; Cinzia Valeria RUSSO ; Francesco SACCÀ ; Roberta LANZILLO ; Vincenzo BRESCIA MORRA
International Neurourology Journal 2021;25(4):310-318
Purpose:
The aim of this study was to evaluate the prevalence of bowel/bladder dysfunction in multiple sclerosis (MS) and its associations with cognitive impairment.
Methods:
We prospectively enrolled 150 MS patients. Patients were administered the Symbol Digit Modality Test (SDMT), the Neurogenic Bowel Dysfunction Score (NBDS), and the Actionable Bladder Symptom Screening Tool (ABSST). The associations between bowel/bladder dysfunction and cognitive function were assessed through hierarchical regression models using the SDMT and clinicodemographic features as independent variables and NBDS and ABSST scores as dependent variables.
Results:
The prevalence of bowel/bladder deficits was 44.7%, with 26 patients (17.3%) suffering from bowel deficits and 60 patients (40%) from bladder deficits. The total NBDS and ABSST scores were correlated with the SDMT (β=-0.10, P<0.001 and β=-0.03, P=0.04, respectively) after correction for demographic features and physical disability.
Conclusions
Bowel/bladder disorders are common in MS and are associated with both physical and cognitive disability burdens. As SDMT is embedded into routine clinical assessments, a lower score may warrant investigating bowel/bladder dysfunction due to the strong interplay of these factors.
4.Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know
Luca RUSSO ; Giacomo AVESANI ; Benedetta GUI ; Charlotte Marguerite Lucille TROMBADORI ; Vanda SALUTARI ; Maria Teresa PERRI ; Valerio Di PAOLA ; Elena RODOLFINO ; Giovanni SCAMBIA ; Riccardo MANFREDI
Korean Journal of Radiology 2021;22(8):1310-1322
Immunotherapy is an effective treatment option for gynecological malignancies. Radiologists dealing with gynecological patients undergoing treatment with immune checkpoint inhibitors should be aware of unconventional immune-related imaging features for the evaluation of tumor response and immune-related adverse events. In this paper, immune checkpoint inhibitors used for gynecological malignancies and their mechanisms of action are briefly presented. In the second part, patterns of pseudoprogression are illustrated, and different forms of immune-related adverse events are discussed.
5.Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know
Luca RUSSO ; Giacomo AVESANI ; Benedetta GUI ; Charlotte Marguerite Lucille TROMBADORI ; Vanda SALUTARI ; Maria Teresa PERRI ; Valerio Di PAOLA ; Elena RODOLFINO ; Giovanni SCAMBIA ; Riccardo MANFREDI
Korean Journal of Radiology 2021;22(8):1310-1322
Immunotherapy is an effective treatment option for gynecological malignancies. Radiologists dealing with gynecological patients undergoing treatment with immune checkpoint inhibitors should be aware of unconventional immune-related imaging features for the evaluation of tumor response and immune-related adverse events. In this paper, immune checkpoint inhibitors used for gynecological malignancies and their mechanisms of action are briefly presented. In the second part, patterns of pseudoprogression are illustrated, and different forms of immune-related adverse events are discussed.